allAfrica.com on MSN3 小时
Tracking Sick, Small Newborn and Zero Dose to End Preventable Deaths in Children in Cross River
In December 2024, the Child's Rights Bureau of the Federal Ministry of Information and National Orientation in collaboration with the United Nations Children's Fund UNICEF convened a media dialogue in ...
SMA3 小时
US, EU regulators to review higher-dose Spinraza for use in SMA
Regulators in the U.S. and the European Union agreed to review Biogen’s applications for approval of a higher dose Spinraza ...
BioSpace1 天
Biogen Trims Research Workforce, Higher-Dose SMA Drug Accepted for Regulatory Review
In a good-news-bad-news week for Biogen, the company will cut an undisclosed number of employees, just as a higher dose of ...
FDA and EMA review Biogen's higher dose SMA drug
CAMBRIDGE, Mass. - Biogen Inc. (NASDAQ:BIIB), a $20.8 billion biotechnology company with a robust 75.6% gross profit margin, ...
TMCnet1 天
FDA and EMA Accept Applications for Higher Dose Regimen of Nusinersen in SMA
We are pleased to announce that our applications for the higher dose regimen of nusinersen are now under review in the US and Europe,” said Stephanie Fradette, Pharm.D., Head of the Neuromuscular ...
infectiousdiseaseadvisor.com2 天
COVID-19 Vaccine: ACIP Recommends Added Doses in All With IC and Adults 65+
The CDC ACIP recommends 2 doses of the 2024-2025 COVID-19 vaccine for those age 65+ years and 2 or more doses for immunocompromised individuals.